Allergy Therapeutics PLC Stock
Your prediction
Allergy Therapeutics PLC Stock
Heavy losses for Allergy Therapeutics PLC today as the stock fell by -€0.005 (-8.330%).
Pros and Cons of Allergy Therapeutics PLC in the next few years
Pros
?
M***** P*******
?
C******** o* t** e**********
?
B****
Cons
?
G***** c******* t* c**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Allergy Therapeutics PLC vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Allergy Therapeutics PLC | -8.330% | 8.108% | -17.241% | -32.203% | -48.718% | 200.000% | -79.452% |
| Eledon Pharmaceuticals Inc. | -2.760% | -10.759% | -15.060% | 10.156% | 120.313% | 141.026% | -48.257% |
| Beximco Pharmaceuticals Ltd. GDR | 0.950% | 16.667% | 16.667% | 23.239% | 17.188% | 36.719% | -39.655% |
| SELLAS Life Sciences Group Inc | 0.000% | -17.788% | -31.120% | 516.022% | 214.638% | 495.461% | 23.889% |
News
"There are no new eras; excesses are never permanent." --Bob Farrell (Rule #3)
TIPPING POINT: BUY LTPZ
TIPPING POINT: BUY LTPZ (July 31, 2026): As I had described in my recent postings, U.S. government debt has become unusually undervalued, with many U.S
AT&T Just Expanded Its Use of D-Wave Quantum's Tech. Time to Buy This Leading Quantum-Computing Stock?
AT&T (NYSE: T) recently announced it's expanding its use of D-Wave Quantum (NASDAQ: QBTS) technology, just months after it began testing the quantum computing company's services.
AT&T said the
D-Wave Quantum Just Announced an Expanded Deal. Should You Buy the Stock Now?
Shares of D-Wave Quantum (NYSE: QBTS) jumped Monday morning on the announcement that AT&T (NYSE: T) is expanding its use of the company's quantum computing technology across its network operations